SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-21-009606
Filing Date
2021-07-29
Accepted
2021-07-29 16:20:54
Documents
95
Period of Report
2021-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q bpmc-20210630x10q.htm   iXBRL 10-Q 2228730
2 EX-10.1 bpmc-20210630xex10d1.htm EX-10.1 99932
3 EX-31.1 bpmc-20210630xex31d1.htm EX-31.1 11754
4 EX-31.2 bpmc-20210630xex31d2.htm EX-31.2 11832
5 EX-32.1 bpmc-20210630xex32d1.htm EX-32.1 10658
  Complete submission text file 0001558370-21-009606.txt   8554947

Data Files

Seq Description Document Type Size
6 EX-101.SCH bpmc-20210630.xsd EX-101.SCH 64161
7 EX-101.CAL bpmc-20210630_cal.xml EX-101.CAL 62088
8 EX-101.DEF bpmc-20210630_def.xml EX-101.DEF 239582
9 EX-101.LAB bpmc-20210630_lab.xml EX-101.LAB 483491
10 EX-101.PRE bpmc-20210630_pre.xml EX-101.PRE 432642
11 EXTRACTED XBRL INSTANCE DOCUMENT bpmc-20210630x10q_htm.xml XML 1492436
Mailing Address 45 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 45 SIDNEY STREET CAMBRIDGE MA 02139 617-374-7580
Blueprint Medicines Corp (Filer) CIK: 0001597264 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37359 | Film No.: 211127750
SIC: 2834 Pharmaceutical Preparations